AstraZeneca has lined up a $1.2 billion takeover deal for Chinese biotech Gracell Biotechnologies, bolting a series of cell therapies for cancer and autoimmune diseases onto its pipeline.

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...

A study led by Samer Srour, MB, ChB, MS, focuses on AIC100, a novel third-generation CAR T-cell therapy specifically engineered to target ICAM-1 (Intercellular Adhesion Molecule-1), a protein ...

Security personnel at the site of attack at the Baisaran Valley in Pahalgam, Jammu and Kashmir. (PTI Photo/File) tension between India and Pakistan post-Pahalgam ...

Background: Th2 polarization is the primary characteristic of airway allergy (AA) and many other immune disorders. Further elucidation of its mechanism is necessary. The immune cells of patients with ...

Isolation and Identification of Compounds from Bioactive Extracts of Taraxacum officinale Weber ex F. H. Wigg. (Dandelion) as a Potential Source of Antibacterial Agents.